Funder
UCL Institute of Ophthalmology, University College London
Wellcome Trust
Moorfields Eye Hospital NHS Foundation Trust
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
Foundation Fighting Blindness
Reference41 articles.
1. Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options;Rahman;Br J Ophthalmol,2020
2. Identification of the gene responsible for Best macular dystrophy;Petrukhin;Nat Genet,1998
3. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium;Marmorstein;Proc Natl Acad Sci U S A,2000
4. Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium;Marmorstein;Mol Vis,2015
5. Gass J. Best’s disease. In: Stereoscopic Atlas of Macular Diseases. Diagnosis and Treatment. Mosby; 1997.